Literature DB >> 16850752

Epidemiology of hepatitis B, C, D and G viruses and cytokine levels among intravenous drug users.

Jianrong Li1, Jing Wang, Kunlun Tian, Yixin Wang, Lei Zhang, Hanju Huang.   

Abstract

To investigate the features of various hepatitis virus infection in intravenous drug users (IVDU), we conducted an epidemiological survey of hepatitis viruses including hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV) and hepatitis G virus (HGV) in IVDU. The correlation of TH lymphocyte cytokine and hepatitis virus infection was examined. A study population of 406 IVDU consisted of 383 males and 23 females. HBV-DNA and HCV-RNA were detected by fluorescence quantitative polymerase chain reaction. HBsAg, HBeAg, anti-HBc, anti-HCV, HDV-Ag and anti-HGV were assayed by ELISA. The levels of cytokines of TH1 and TH2 were measured by ELISA. The similar indices taken from 102 healthy persons served as controls. The infection rate of each virus among IVDU was 36.45 % for HBV, 69.7 % for HCV, 2.22 % for HDV, and 1.97 % for HGV, respectively. The co-infection rate of HBV and HCV was detected in 113 of 406 (27.83 %). In contrast, among controls, the infection rate was 17.65 % for HBV and 0 % for the other hepatitis viruses. The levels of PHA-induced cytokines (IFN-gamma and IL-4) and the level of serum IL-2 were obviously decreased in IVDU. On the other hand, the level of serum IL-4 was increased. The IFN-gamma level was continuously decreased when the IVDU was infected with HBV/HCV. In conclusion, HBV and HCV infection were common in this population of IVDU and they had led to a high incidence of impaired TH1 cytokine levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16850752     DOI: 10.1007/bf02895821

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  17 in total

1.  Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C.

Authors:  L Kazemi-Shirazi; D Petermann; C Müller
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

2.  Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.

Authors:  J A Hahn; K Page-Shafer; P J Lum; K Ochoa; A R Moss
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

3.  The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome.

Authors:  M Smolka; L G Schmidt
Journal:  Addiction       Date:  1999-08       Impact factor: 6.526

4.  Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection.

Authors:  R J Gilson; A E Hawkins; M R Beecham; E Ross; J Waite; M Briggs; T McNally; G E Kelly; R S Tedder; I V Weller
Journal:  AIDS       Date:  1997-04       Impact factor: 4.177

5.  Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users.

Authors:  J R Pallás; C Fariñas-Alvarez; D Prieto; M Delgado-Rodríguez
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

6.  Modulation of infection and type 1 cytokine expression parameters by morphine during in vitro coinfection with human T-cell leukemia virus type I and HIV-1.

Authors:  Susan B Nyland; Chuanhai Cao; Yun Bai; Thomas P Loughran; Kenneth E Ugen
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-01       Impact factor: 3.731

7.  Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China.

Authors:  Rebecca J Garten; Shenghan Lai; Jinbing Zhang; Wei Liu; Jie Chen; David Vlahov; Xiao-Fang Yu
Journal:  Int J Epidemiol       Date:  2004-02       Impact factor: 7.196

8.  Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha.

Authors:  Michael Frese; Kerstin Barth; Artur Kaul; Volker Lohmann; Verena Schwärzle; Ralf Bartenschlager
Journal:  J Gen Virol       Date:  2003-05       Impact factor: 3.891

9.  High seroprevalence of bloodborne viruses among street-recruited injection drug users from Buenos Aires, Argentina.

Authors:  Mercedes Weissenbacher; Diana Rossi; Graciela Radulich; Sergio Sosa-Estáni; Marcelo Vila; Enrique Vivas; María M Avila; Paloma Cuchi; Jorge Rey; Liliana Martínez Peralta
Journal:  Clin Infect Dis       Date:  2003-12-15       Impact factor: 9.079

10.  Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users.

Authors:  Nanping Wu; Dan Li; Biao Zhu; Wei Zou
Journal:  Chin Med J (Engl)       Date:  2003-09       Impact factor: 2.628

View more
  3 in total

Review 1.  Hepatitis D Virus: Introduction and Epidemiology.

Authors:  Mario Rizzetto
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

Review 2.  Hepatitis D: Scenario in the Asia-Pacific region.

Authors:  Zaigham Abbas; Wasim Jafri; Sajjad Raza
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

3.  Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysis.

Authors:  Víctor Granados-García; Yvonne N Flores; Lizbeth I Díaz-Trejo; Lucia Méndez-Sánchez; Stephanie Liu; Guillermo Salinas-Escudero; Filiberto Toledano-Toledano; Jorge Salmerón
Journal:  PLoS One       Date:  2019-02-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.